Advent and Aurora Investment offers to buy Sweden's SOBI in $8- bln deal (updated)

Investor AB

02/09/2021 07:02

(Adds detail, background)
    STOCKHOLM, Sept 2 (Reuters) - U.S. venture capital firm
Advent International and Aurora Investment, an affiliate of
capital market firm GIC, has offered to buy Swedish Orphan
Biovitrum (SOBI)  SOBIV.ST  in a deal valuing it at about 69.4
billion Swedish crowns ($8 billion).
    SOBI said the two firms had offered 235 Swedish crowns 
($27.3) for each share through Agnafit Bidco AB.
    Investors AB  INVEb.ST  and Fjärde AP-Fonden, with SOBI
stakes of about 36.45% and 6.96% respectively, have separately
agreed to accept the offer, the company said, adding that its
board had unanimously recommended that shareholders accept.
    SOBI said the offer price was a premium of about 34.5% to
its Aug. 25 closing price of 174.70 crowns on Nasdaq Stockholm.
    "The board believes that the terms of the offer recognise
SOBI’s long-term growth prospects, as well as the risks
associated with those prospects, and provide certainty, in cash,
to shareholders," it said.
($1=8.6178 Swedish crowns)

 (Reporting by Helena Soderpalm; Editing by Clarence Fernandez)
 ((helena.soderpalm@thomsonreuters.com; +46 8 700 10 15; Reuters
Messaging: helena.soderpalm.reuters.com@reuters.net))